| ASSET | QUARTER | % RETURN |
|---|---|---|
Moderna (MRNA) | Q2 2020 | 113.68% |
Moderna (MRNA) | Q2 2021 | 77.75% |
Moderna (MRNA) | Q1 2026 | 70.3% |
Moderna (MRNA) | Q3 2021 | 62.87% |
Moderna (MRNA) | Q1 2020 | 53.04% |
Moderna (MRNA) | Q4 2022 | 50.54% |
Moderna (MRNA) | Q4 2020 | 50.17% |
Gladstone Investment (GAIN) | Q2 2020 | 40.49% |
Moderna (MRNA) | Q1 2019 | 36.3% |
Gladstone Investment (GAIN) | Q2 2009 | 35.62% |
Gladstone Investment (GAIN) | Q1 2010 | 31.27% |
Gladstone Investment (GAIN) | Q1 2019 | 27.64% |
Gladstone Investment (GAIN) | Q3 2016 | 26.99% |
Gladstone Investment (GAIN) | Q4 2021 | 24.59% |
Gladstone Investment (GAIN) | Q1 2021 | 23.28% |
Moderna (MRNA) | Q4 2019 | 23.25% |
Moderna (MRNA) | Q1 2021 | 22.12% |
Gladstone Investment (GAIN) | Q3 2010 | 21.5% |
Gladstone Investment (GAIN) | Q4 2023 | 21.31% |
Gladstone Investment (GAIN) | Q4 2017 | 20.17% |
Gladstone Investment (GAIN) | Q2 2021 | 19.7% |
Gladstone Investment (GAIN) | Q2 2026 | 19.58% |
Gladstone Investment (GAIN) | Q2 2018 | 19.1% |
Gladstone Investment (GAIN) | Q4 2013 | 17.8% |
Gladstone Investment (GAIN) | Q4 2010 | 15.17% |